Genzyme Corporate Research Search Genzyme Websites
PatientsHealth Care ProfessionalsPayors
Thyrogen
Patient Overview
Newly Diagnosed
Follow-up
What To Expect
Testing
Role of Thyrogen
Thyroid Cancer Recurrence
Reimbursement
Resources
Product Information (PDF)

What to Expect in the Years Following Therapy

Having any type of cancer will undoubtedly change your life. It’s normal to feel frightened and as though your life will never be “normal” again. As you’ve read, the outlook for surviving well-differentiated thyroid cancer (WDTC) is generally good – the overall 5-year survival rate is 96%. For more information about thyroid cancer, please visit the Newly Diagnosed section. Once you’ve been through your initial treatment and are taking thyroid hormone therapy, you can likely look forward to a more normal life.

It is still important to bear in mind that recurrences are possible many years — even decades — after treatment. Long-term studies have shown that:

  • As many as 30% of patients with WDTC will experience a recurrence
  • One third of all recurrences may happen 10 years or more after initial treatment

These numbers shouldn’t be frightening, since many recurrences of well-differentiated thyroid cancer are treatable. However, the prognosis is improved if you catch a recurrence relatively early. As you can see, it’s important to keep having follow-up tests.

In the first few years after treatment for thyroid cancer, your doctor may want to do routine tests relatively often. Depending on your doctor’s recommendation and your individual condition, you may go for tests annually, or perhaps more frequently until you and your doctor are comfortable with less frequent monitoring.

Regular follow-ups can include:

  • Routine physical exams
  • Thyroglobulin (Tg) tests
  • Whole body scans

Even though most routine examinations may not uncover anything to be concerned about, it is possible that you may develop recurrent cancer in the thyroid area or in other areas of the body. More information about this possibility can be found in the Recurrence section.


Safety Information
Thyrogen® (thyrotropin alfa for injection) is used in combination with other tests to detect recurring or leftover thyroid cancer cells in patients with a history of certain types of thyroid cancer. Thyrogen is injected in a muscle, and is available only by prescription. The most common side effects reported in clinical studies were nausea, headache, weakness & vomiting. When using Thyrogen, there is a risk that thyroid cancer cells may not be detected and diagnosis of recurring cancer may be missed. If you think that Thyrogen may be right for you, or if you have any problems with the use of Thyrogen, please contact your doctor. To learn more, please see full product information (PDF), contact Genzyme toll free at 1-88-THYROGEN (1-888-497-6436).
Search Thyrogen
Keyword: 
Search In: 
 
Highlight

Take Action Early

If you or someone you know has Thyroid Cancer, the more you know about this disease and its management the better. Here are some additional resources for patients.

Resources
Related Links
Testing Schedule
Patient Education Materials
Request Materials
Events Calendar
Low-iodine Diet
Glossary
Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
888 497 6436
617 768 8050
Contact Genzyme



 
Thyrogen Terms and Conditions of Use | Privacy Policy | This site is intended for United States residents only © 2003-2008 Genzyme Corporation. All rights reserved. Genzyme